Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2024(Status and Outlook)
Report Overview:
Non-24-hour sleep-wake disorder (N24) isa circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
The Global Non-24-hour Sleep-wake Disorder Treatment Market Size was estimated at USD 510.05 million in 2023 and is projected to reach USD 727.62 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.
This report provides a deep insight into the global Non-24-hour Sleep-wake Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-24-hour Sleep-wake Disorder Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-24-hour Sleep-wake Disorder Treatment market in any manner.
Global Non-24-hour Sleep-wake Disorder Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Market Segmentation (by Type)
Prescription Drugs
OTC
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-24-hour Sleep-wake Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Non-24-hour sleep-wake disorder (N24) isa circadian rhythm sleep disorder in which an individual's biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.
The Global Non-24-hour Sleep-wake Disorder Treatment Market Size was estimated at USD 510.05 million in 2023 and is projected to reach USD 727.62 million by 2029, exhibiting a CAGR of 6.10% during the forecast period.
This report provides a deep insight into the global Non-24-hour Sleep-wake Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-24-hour Sleep-wake Disorder Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-24-hour Sleep-wake Disorder Treatment market in any manner.
Global Non-24-hour Sleep-wake Disorder Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Mylan
Nature’s Bounty
Otsuka Pharma (Pharmavite)
Boiron
Miers Laboratories
Genexa
Homeocan
Clinigen Group
Vanda Pharma
Market Segmentation (by Type)
Prescription Drugs
OTC
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-24-hour Sleep-wake Disorder Treatment Market
- Overview of the regional outlook of the Non-24-hour Sleep-wake Disorder Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-24-hour Sleep-wake Disorder Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Key Market Segments
1.2.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
1.2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Manufacturers (2019-2024)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-24-hour Sleep-wake Disorder Treatment Sales Sites, Area Served, Product Type
3.6 Non-24-hour Sleep-wake Disorder Treatment Market Competitive Situation and Trends
3.6.1 Non-24-hour Sleep-wake Disorder Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-24-hour Sleep-wake Disorder Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2019-2024)
6.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Non-24-hour Sleep-wake Disorder Treatment Price by Type (2019-2024)
7 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Sales by Application (2019-2024)
7.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
8 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Mylan
9.2.1 Mylan Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.2.4 Mylan Business Overview
9.2.5 Mylan Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.2.6 Mylan Recent Developments
9.3 Nature’s Bounty
9.3.1 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.3.2 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.3.5 Nature’s Bounty Business Overview
9.3.6 Nature’s Bounty Recent Developments
9.4 Otsuka Pharma (Pharmavite)
9.4.1 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.4.4 Otsuka Pharma (Pharmavite) Business Overview
9.4.5 Otsuka Pharma (Pharmavite) Recent Developments
9.5 Boiron
9.5.1 Boiron Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.5.4 Boiron Business Overview
9.5.5 Boiron Recent Developments
9.6 Miers Laboratories
9.6.1 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.6.4 Miers Laboratories Business Overview
9.6.5 Miers Laboratories Recent Developments
9.7 Genexa
9.7.1 Genexa Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.7.4 Genexa Business Overview
9.7.5 Genexa Recent Developments
9.8 Homeocan
9.8.1 Homeocan Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.8.4 Homeocan Business Overview
9.8.5 Homeocan Recent Developments
9.9 Clinigen Group
9.9.1 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.9.4 Clinigen Group Business Overview
9.9.5 Clinigen Group Recent Developments
9.10 Vanda Pharma
9.10.1 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.10.4 Vanda Pharma Business Overview
9.10.5 Vanda Pharma Recent Developments
10 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST BY REGION
10.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast
10.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region
10.2.4 South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-24-hour Sleep-wake Disorder Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Type (2025-2030)
11.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-24-hour Sleep-wake Disorder Treatment by Type (2025-2030)
11.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-24-hour Sleep-wake Disorder Treatment
1.2 Key Market Segments
1.2.1 Non-24-hour Sleep-wake Disorder Treatment Segment by Type
1.2.2 Non-24-hour Sleep-wake Disorder Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Manufacturers (2019-2024)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-24-hour Sleep-wake Disorder Treatment Sales Sites, Area Served, Product Type
3.6 Non-24-hour Sleep-wake Disorder Treatment Market Competitive Situation and Trends
3.6.1 Non-24-hour Sleep-wake Disorder Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-24-hour Sleep-wake Disorder Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Non-24-hour Sleep-wake Disorder Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2019-2024)
6.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Non-24-hour Sleep-wake Disorder Treatment Price by Type (2019-2024)
7 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Sales by Application (2019-2024)
7.3 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
8 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET SEGMENTATION BY REGION
8.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.1.2 Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Mylan
9.2.1 Mylan Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.2.2 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.2.4 Mylan Business Overview
9.2.5 Mylan Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.2.6 Mylan Recent Developments
9.3 Nature’s Bounty
9.3.1 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.3.2 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.3.4 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
9.3.5 Nature’s Bounty Business Overview
9.3.6 Nature’s Bounty Recent Developments
9.4 Otsuka Pharma (Pharmavite)
9.4.1 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.4.2 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.4.4 Otsuka Pharma (Pharmavite) Business Overview
9.4.5 Otsuka Pharma (Pharmavite) Recent Developments
9.5 Boiron
9.5.1 Boiron Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.5.2 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.5.4 Boiron Business Overview
9.5.5 Boiron Recent Developments
9.6 Miers Laboratories
9.6.1 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.6.2 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.6.4 Miers Laboratories Business Overview
9.6.5 Miers Laboratories Recent Developments
9.7 Genexa
9.7.1 Genexa Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.7.2 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.7.4 Genexa Business Overview
9.7.5 Genexa Recent Developments
9.8 Homeocan
9.8.1 Homeocan Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.8.2 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.8.4 Homeocan Business Overview
9.8.5 Homeocan Recent Developments
9.9 Clinigen Group
9.9.1 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.9.2 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.9.4 Clinigen Group Business Overview
9.9.5 Clinigen Group Recent Developments
9.10 Vanda Pharma
9.10.1 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Basic Information
9.10.2 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
9.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Market Performance
9.10.4 Vanda Pharma Business Overview
9.10.5 Vanda Pharma Recent Developments
10 NON-24-HOUR SLEEP-WAKE DISORDER TREATMENT MARKET FORECAST BY REGION
10.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast
10.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region
10.2.4 South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-24-hour Sleep-wake Disorder Treatment by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-24-hour Sleep-wake Disorder Treatment by Type (2025-2030)
11.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-24-hour Sleep-wake Disorder Treatment by Type (2025-2030)
11.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Region (M USD)
Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2022)
Table 10. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-24-hour Sleep-wake Disorder Treatment Sales Sites and Area Served
Table 12. Manufacturers Non-24-hour Sleep-wake Disorder Treatment Product Type
Table 13. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-24-hour Sleep-wake Disorder Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-24-hour Sleep-wake Disorder Treatment Market Challenges
Table 22. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Type (Kilotons)
Table 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 24. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Share by Type (2019-2024)
Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Application
Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 31. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2019-2024)
Table 35. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 44. Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 45. Teva Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Mylan Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 50. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 51. Mylan Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan Business Overview
Table 53. Mylan Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 54. Mylan Recent Developments
Table 55. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 56. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 57. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 59. Nature’s Bounty Business Overview
Table 60. Nature’s Bounty Recent Developments
Table 61. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 62. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 63. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Otsuka Pharma (Pharmavite) Business Overview
Table 65. Otsuka Pharma (Pharmavite) Recent Developments
Table 66. Boiron Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 67. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 68. Boiron Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Boiron Business Overview
Table 70. Boiron Recent Developments
Table 71. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 72. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 73. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Miers Laboratories Business Overview
Table 75. Miers Laboratories Recent Developments
Table 76. Genexa Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 77. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 78. Genexa Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Genexa Business Overview
Table 80. Genexa Recent Developments
Table 81. Homeocan Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 82. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 83. Homeocan Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Homeocan Business Overview
Table 85. Homeocan Recent Developments
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 87. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 88. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clinigen Group Business Overview
Table 90. Clinigen Group Recent Developments
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 92. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 93. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vanda Pharma Business Overview
Table 95. Vanda Pharma Recent Developments
Table 96. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Non-24-hour Sleep-wake Disorder Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Region (M USD)
Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2022)
Table 10. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-24-hour Sleep-wake Disorder Treatment Sales Sites and Area Served
Table 12. Manufacturers Non-24-hour Sleep-wake Disorder Treatment Product Type
Table 13. Global Non-24-hour Sleep-wake Disorder Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-24-hour Sleep-wake Disorder Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-24-hour Sleep-wake Disorder Treatment Market Challenges
Table 22. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Type (Kilotons)
Table 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (M USD)
Table 24. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Share by Type (2019-2024)
Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) by Application
Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application
Table 31. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2019-2024)
Table 35. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Non-24-hour Sleep-wake Disorder Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 44. Teva Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 45. Teva Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Mylan Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 50. Mylan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 51. Mylan Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan Business Overview
Table 53. Mylan Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 54. Mylan Recent Developments
Table 55. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 56. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 57. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment SWOT Analysis
Table 59. Nature’s Bounty Business Overview
Table 60. Nature’s Bounty Recent Developments
Table 61. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 62. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 63. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Otsuka Pharma (Pharmavite) Business Overview
Table 65. Otsuka Pharma (Pharmavite) Recent Developments
Table 66. Boiron Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 67. Boiron Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 68. Boiron Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Boiron Business Overview
Table 70. Boiron Recent Developments
Table 71. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 72. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 73. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Miers Laboratories Business Overview
Table 75. Miers Laboratories Recent Developments
Table 76. Genexa Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 77. Genexa Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 78. Genexa Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Genexa Business Overview
Table 80. Genexa Recent Developments
Table 81. Homeocan Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 82. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 83. Homeocan Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Homeocan Business Overview
Table 85. Homeocan Recent Developments
Table 86. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 87. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 88. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clinigen Group Business Overview
Table 90. Clinigen Group Recent Developments
Table 91. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Basic Information
Table 92. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product Overview
Table 93. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vanda Pharma Business Overview
Table 95. Vanda Pharma Recent Developments
Table 96. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Non-24-hour Sleep-wake Disorder Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-24-hour Sleep-wake Disorder Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD), 2019-2030
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (M USD)
Figure 11. Non-24-hour Sleep-wake Disorder Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers in 2023
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type
Figure 18. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2023
Figure 20. Market Size Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application
Figure 24. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application in 2023
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2019-2024)
Figure 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application in 2023
Figure 28. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Non-24-hour Sleep-wake Disorder Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 37. Germany Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2023
Figure 44. China Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Non-24-hour Sleep-wake Disorder Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD), 2019-2030
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (M USD)
Figure 11. Non-24-hour Sleep-wake Disorder Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Share by Manufacturers in 2023
Figure 13. Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-24-hour Sleep-wake Disorder Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type
Figure 18. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2023
Figure 20. Market Size Share of Non-24-hour Sleep-wake Disorder Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Non-24-hour Sleep-wake Disorder Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application
Figure 24. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Application in 2023
Figure 26. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application (2019-2024)
Figure 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application in 2023
Figure 28. Global Non-24-hour Sleep-wake Disorder Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Non-24-hour Sleep-wake Disorder Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Non-24-hour Sleep-wake Disorder Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 37. Germany Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2023
Figure 44. China Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Non-24-hour Sleep-wake Disorder Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Non-24-hour Sleep-wake Disorder Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-24-hour Sleep-wake Disorder Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-24-hour Sleep-wake Disorder Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Non-24-hour Sleep-wake Disorder Treatment Market Share Forecast by Application (2025-2030)
